store
finder
Shop Online at Pharmasave shop
online
weekly
flyer
Email  
Sign Up

COVID-19 Vaccines

What you need to know about getting a COVID-19 vaccination

As determined by provincial and territorial governments, some Pharmasave stores are now administering the COVID-19 Vaccine to eligible individuals. Participation varies by province. Details and frequently asked questions can be found below.

Pharmasave is aware of the questions you may have regarding the AstraZeneca COVID-19 vaccine. We continue to follow the guidance of Health Canada, the Public Health Agency of Canada (PHAC), the National Advisory Committee on Immunization (NACI) and jurisdictions across Canada. For more information, please read more at National Advisory Committee on Immunization: Summary of updated vaccine statement of June 17, 2021.

For information on owning or selling a pharmacy please contact us. We can discuss how Pharmasave can help you optimize your business.

For information on owning or selling a pharmacy please contact us. We can discuss how Pharmasave can help you optimize your business.

For information on owning or selling a pharmacy please contact us. We can discuss how Pharmasave can help you optimize your business.

For information on owning or selling a pharmacy please contact us. We can discuss how Pharmasave can help you optimize your business.

For information on owning or selling a pharmacy please contact us. We can discuss how Pharmasave can help you optimize your business.

  • New Brunswick, Newfoundland and Labrador, Nova Scotia,
    Prince Edward Island


    New Franchise Inquiries Contact:
    Doug Sherman, Chief Executive Officer
    Pharmasave Drugs (East) Ltd.
    Direct: (905) 477-7820 | Toll Free: 1-800-515-6820Michael Thompson, Director, Business and Retail Development
    Email: mthompson@east.pharmasave.ca

For information on owning or selling a pharmacy please contact us. We can discuss how Pharmasave can help you optimize your business.

  • New Brunswick, Newfoundland and Labrador, Nova Scotia,
    Prince Edward Island


    New Franchise Inquiries Contact:
    Doug Sherman, Chief Executive Officer
    Pharmasave Drugs (East) Ltd.
    Direct: (905) 477-7820 | Toll Free: 1-800-515-6820Michael Thompson, Director, Business and Retail Development
    Email: mthompson@east.pharmasave.ca

For information on owning or selling a pharmacy please contact us. We can discuss how Pharmasave can help you optimize your business.

  • New Brunswick, Newfoundland and Labrador, Nova Scotia,
    Prince Edward Island


    New Franchise Inquiries Contact:
    Doug Sherman, Chief Executive Officer
    Pharmasave Drugs (East) Ltd.
    Direct: (905) 477-7820 | Toll Free: 1-800-515-6820Michael Thompson, Director, Business and Retail Development
    Email: mthompson@east.pharmasave.ca

For information on owning or selling a pharmacy please contact us. We can discuss how Pharmasave can help you optimize your business.

  • New Brunswick, Newfoundland and Labrador, Nova Scotia,
    Prince Edward Island


    New Franchise Inquiries Contact:
    Doug Sherman, Chief Executive Officer
    Pharmasave Drugs (East) Ltd.
    Direct: (905) 477-7820 | Toll Free: 1-800-515-6820Michael Thompson, Director, Business and Retail Development
    Email: mthompson@east.pharmasave.ca

Ownership contacts

What is Pharmasave’s role in COVID-19 vaccinations?

As determined by federal and provincial governments, Pharmasave’s certified injection pharmacists will administer the vaccine safely and effectively to people who are eligible based on the provincial government roll-out plans. For information about Pharmasave stores providing the COVID-19 vaccine in your province, click on your province from the list above.

When will COVID-19 vaccines be available in Pharmasave for everyone?

Some provinces are testing the vaccine rollout in select pharmacies before expanding the program. As the rollout continues in each province, and as governments advise, more Pharmasave pharmacies will begin to offer COVID-19 vaccinations.

Timing for other Pharmasave pharmacies will depend on vaccine allocation from federal and provincial governments as well as phased eligibility. For information about Pharmasave stores providing the COVID-19 vaccine in your province, click on your province from the list above.

Who is prioritized to receive the COVID-19 vaccine?

The Government of Canada’s National Advisory Committee on Immunization (NACI) provides advice to the Public Health Agency of Canada on priority of COVID-19 vaccination for population groups.

With this advice, provinces and territories have developed detailed COVID-19 immunization rollout plans for their residents including which population will receive the vaccine first. Click here to learn more.

For immunization rollout phases including timelines and eligibility, click on your respective province:

British Columbia
Alberta
Saskatchewan
Manitoba
Ontario
New Brunswick
Newfoundland & Labrador
Nova Scotia
Prince Edward Island
Yukon

What are the rollout plans for the COVID-19 Vaccine across Canada?

Rollout plans are being developed and implemented by provincial and territorial governments, taking into consideration Canada’s 7-point COVID-19 Immunization Plan and NACI’s Recommendations for Use of Coronavirus Vaccines. Priority populations include seniors, health care workers, long-term care residents and Indigenous communities.

How will community pharmacies support COVID-19 vaccination?

There are a number of key roles that community pharmacies and the pharmacy workforce can play in supporting Canada’s COVID-19 vaccination rollout strategy. These strategies include decreasing vaccine hesitancy, increasing awareness, helping triage priority populations and monitoring for adverse effects, as well as administering the vaccine.

Some provinces are including community pharmacies in their rollout plans to administer vaccines. Process and eligibility vary by province. Click on your province from the list above for participating Pharmasave locations.

Which COVID-19 vaccines are presently approved for use in Canada?

To date, the following vaccines have been authorized for use in Canada:

  • Pfizer-BioNTech COVID-19 vaccine
    • 2 dose regimen, 21 days apart
    • If possible, the COVID-19 vaccine should not be given within 14 days of receiving any other vaccine
    • At a minimum, 28 days should elapse after the second dose of the COVID-19 vaccine before receiving any additional vaccines
  • Moderna COVID-19 vaccine
    • 2 dose regimen, 28 days apart
    • If possible, the COVID-19 vaccine should not be given within 14 days of receiving any other vaccine
    • At a minimum, 28 days should elapse after the second dose of the COVID-19 vaccine before receiving any additional vaccines
  • AstraZeneca COVID-19 Vaccine
    • 2 dose regimen, 4 to 12 weeks later
    • If possible, the COVID-19 vaccine should not be given 14 days after receiving any other vaccine
    • At a minimum, 28 days should elapse after the second dose of the COVID-19 vaccine before receiving any additional vaccines
  • Janssen (Johnson & Johnson) COVID-19 Vaccine
    • A single dose regimen
    • If possible, the COVID-19 vaccine should not be given 14 days after receiving any other vaccine
    • At a minimum, 28 days should elapse after receiving the COVID-19 vaccine before receiving any additional vaccines

How safe and effective are the COVID-19 vaccines?

Studies for each of the approved COVID-19 vaccines in Canada were conducted in different populations around the world, at different times during the pandemic and not in head-to-head comparative studies. Numerous scientific, peer-reviewed studies have shown that all the approved COVID-19 vaccines in Canada have gone through rigorous testing and clinical trials to ensure they meet the highest safety standard. All the approved vaccines have shown high efficacy in the most important outcomes: reducing severe symptoms of COVID-19, hospitalization, and death.

Are there any side effects associated with receiving the COVID-19 vaccine?

Serious adverse effects from any COVID vaccine are rare. Common adverse events include injection site pain, fatigue, headache, and muscle pain. Health Canada is closely monitoring any reports of adverse events from the population as people receive the vaccine, and there have been no reports of unexpected side effects from patients to date. Anyone who witnesses or experiences an adverse reaction to the vaccine is encouraged to report the reaction to their health care provider.

Can COVID-19 vaccines be administered in different dosing intervals?

Due to recent vaccine supply and distribution challenges, the Government of Canada is revisiting the immunization schedule and NACI has published guidance that outlines key factors for consideration when adjusted dosing intervals may be required. Public Health authorities are advising, based on the most current evidence available, that “the interval between doses should be extended up to four months (i.e. 16 weeks)”.  QA-Guide.pdf (bluecross.ca)

Share this page

facebook twitter linkedin